Literature DB >> 29671217

Cyproheptadine Regulates Pyramidal Neuron Excitability in Mouse Medial Prefrontal Cortex.

Yan-Lin He1, Kai Wang2, Qian-Ru Zhao2, Yan-Ai Mei3.   

Abstract

Cyproheptadine (CPH), a first-generation antihistamine, enhances the delayed rectifier outward K+ current (IK) in mouse cortical neurons through a sigma-1 receptor-mediated protein kinase A pathway. In this study, we aimed to determine the effects of CPH on neuronal excitability in current-clamped pyramidal neurons in mouse medial prefrontal cortex slices. CPH (10 µmol/L) significantly reduced the current density required to generate action potentials (APs) and increased the instantaneous frequency evoked by a depolarizing current. CPH also depolarized the resting membrane potential (RMP), decreased the delay time to elicit an AP, and reduced the spike threshold potential. This effect of CPH was mimicked by a sigma-1 receptor agonist and eliminated by an antagonist. Application of tetraethylammonium (TEA) to block IK channels hyperpolarized the RMP and reduced the instantaneous frequency of APs. TEA eliminated the effects of CPH on AP frequency and delay time, but had no effect on spike threshold or RMP. The current-voltage relationship showed that CPH increased the membrane depolarization in response to positive current pulses and hyperpolarization in response to negative current pulses, suggesting that other types of membrane ion channels might also be affected by CPH. These results suggest that CPH increases the excitability of medial prefrontal cortex neurons by regulating TEA-sensitive IK channels as well as other TEA-insensitive K+ channels, probably ID and inward-rectifier Kir channels. This effect of CPH may explain its apparent clinical efficacy as an antidepressant and antipsychotic.

Entities:  

Keywords:  Cyproheptadine; Neuronal excitability; Sigma-1 receptor; Tetraethylammonium-sensitive I K; cortical neurons

Mesh:

Substances:

Year:  2018        PMID: 29671217      PMCID: PMC6129243          DOI: 10.1007/s12264-018-0225-7

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  29 in total

1.  A comparison of the antiserotonin, antihistamine, and anticholinergic activity of cyproheptadine with analogues having furan nuclei fused to the 10,11-vinylene bridge.

Authors:  D C Remy; A W Raab; K E Rittle; E L Engelhardt; A Scriabine; V J Lotti
Journal:  J Med Chem       Date:  1977-06       Impact factor: 7.446

Review 2.  Prefrontal cortex and working memory processes.

Authors:  S Funahashi
Journal:  Neuroscience       Date:  2005-12-01       Impact factor: 3.590

3.  Neuritin Enhances Synaptic Transmission in Medial Prefrontal Cortex in Mice by Increasing CaV3.3 Surface Expression.

Authors:  Jun-Mei Lu; Dong-Dong Liu; Zhao-Yang Li; Chen Ling; Yan-Ai Mei
Journal:  Cereb Cortex       Date:  2017-07-01       Impact factor: 5.357

4.  Roles of specific Kv channel types in repolarization of the action potential in genetically identified subclasses of pyramidal neurons in mouse neocortex.

Authors:  Dhruba Pathak; Dongxu Guan; Robert C Foehring
Journal:  J Neurophysiol       Date:  2016-02-10       Impact factor: 2.714

Review 5.  Functional and dysfunctional synaptic plasticity in prefrontal cortex: roles in psychiatric disorders.

Authors:  Yukiori Goto; Charles R Yang; Satoru Otani
Journal:  Biol Psychiatry       Date:  2009-10-14       Impact factor: 13.382

Review 6.  The pharmacology of sigma-1 receptors.

Authors:  Tangui Maurice; Tsung-Ping Su
Journal:  Pharmacol Ther       Date:  2009-07-18       Impact factor: 12.310

7.  Cyproheptadine-induced myeloma cell apoptosis is associated with inhibition of the PI3K/AKT signaling.

Authors:  Jie Li; Biyin Cao; Shunye Zhou; Jingyu Zhu; Zubin Zhang; Tingjun Hou; Xinliang Mao
Journal:  Eur J Haematol       Date:  2013-09-18       Impact factor: 2.997

8.  LGI1 tunes intrinsic excitability by regulating the density of axonal Kv1 channels.

Authors:  Michael Seagar; Michael Russier; Olivier Caillard; Yves Maulet; Laure Fronzaroli-Molinieres; Marina De San Feliciano; Norah Boumedine-Guignon; Léa Rodriguez; Mickael Zbili; Fabrice Usseglio; Christine Formisano-Tréziny; Fahamoe Youssouf; Marion Sangiardi; Morgane Boillot; Stéphanie Baulac; María José Benitez; Juan-José Garrido; Dominique Debanne; Oussama El Far
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-03       Impact factor: 11.205

9.  Cyproheptadine, an antihistaminic drug, inhibits proliferation of hepatocellular carcinoma cells by blocking cell cycle progression through the activation of P38 MAP kinase.

Authors:  Yu-Min Feng; Chin-Wen Feng; Syue-Yi Chen; Hsiao-Yen Hsieh; Yu-Hsin Chen; Cheng-Da Hsu
Journal:  BMC Cancer       Date:  2015-03-17       Impact factor: 4.430

10.  Cyproheptadine enhances the I(K) of mouse cortical neurons through sigma-1 receptor-mediated intracellular signal pathway.

Authors:  Yan-Lin He; Chun-Lei Zhang; Xiao-Fei Gao; Jin-Jing Yao; Chang-Long Hu; Yan-Ai Mei
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.